12:43Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
05:17Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
07:29Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
09:45Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines
07:16Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
07:03Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 20, 2026

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
Published on: January 6, 2014
Asmaa Reda1,2, Salma Hosseiny1, Ibrahim M El-Sherbiny1
1Nanomedicine Division, Center for Materials Science, Zewail City of Science & Technology, 12578, Giza, Egypt.
Cancer stem cells (CSCs) drive aggressive cancers and resist conventional treatments. Nanotechnology offers promising nanotheranostics for targeted cancer therapy and early detection by addressing CSCs.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: